SOUTH SAN FRANCISCO, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results